Ascelia Pharma AB: cashflow_investing

Value{"amount": -65000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"}
Period2022-01-01 – 2022-12-31
Statuscurrent
EntityAscelia Pharma AB
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:5493002YR9VCJJPWYN08:2023-12-31
Retrieved: 2026-08-23T23:58:32.725583+02:00
Raw response sha256: 77955d91bfae34156c9ed34b7e96e25e…
Cite as: FACTANKER, https://factanker.com/fact/ac92e150-0444-49be-bf24-02ff7ca2b71f

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies